Barrett Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-5,347
| Closed | -$333K | – | 256 |
|
|
2021
Q4 | $333K | Buy |
5,347
+398
| +8% | +$23.3K | 0.01% | 175 |
|
|
2021
Q3 | $293K | Buy |
4,949
+140
| +3% | +$9.22K | 0.01% | 167 |
|
|
2021
Q2 | $321K | Buy |
4,809
+622
| +15% | +$40.6K | 0.01% | 160 |
|
|
2021
Q1 | $264K | Sell |
4,187
-13,322
| -76% | -$829K | 0.01% | 163 |
|
|
2020
Q4 | $1.09M | Sell |
17,509
-967
| -5% | -$59.5K | 0.06% | 97 |
|
|
2020
Q3 | $1.11M | Buy |
18,476
+1,527
| +9% | +$91.9K | 0.07% | 87 |
|
|
2020
Q2 | $997K | Buy |
16,949
+975
| +6% | +$58.3K | 0.06% | 85 |
|
|
2020
Q1 | $890K | Buy |
15,974
+12,650
| +381% | +$773K | 0.07% | 87 |
|
|
2019
Q4 | $213K | Sell |
3,324
-15,185
| -82% | -$870K | 0.01% | 145 |
|
|
2019
Q3 | $939K | Sell |
18,509
-14,750
| -44% | -$693K | 0.06% | 92 |
|
|
2019
Q2 | $1.51M | Sell |
33,259
-200,190
| -86% | -$9.32M | 0.1% | 80 |
|
|
2019
Q1 | $11.1M | Sell |
233,449
-2,865
| -1% | -$143K | 0.75% | 43 |
|
|
2018
Q4 | $12.3M | Sell |
236,314
-33,285
| -12% | -$1.79M | 0.94% | 35 |
|
|
2018
Q3 | $16.7M | Sell |
269,599
-7,146
| -3% | -$424K | 1.09% | 34 |
|
|
2018
Q2 | $15.3M | Sell |
276,745
-21,450
| -7% | -$1.16M | 1.04% | 35 |
|
|
2018
Q1 | $18.9M | Buy |
298,195
+5,297
| +2% | +$341K | 1.34% | 32 |
|
|
2017
Q4 | $17.9M | Buy |
292,898
+2,733
| +0.9% | +$171K | 1.26% | 32 |
|
|
2017
Q3 | $18.5M | Buy |
290,165
+5,225
| +2% | +$305K | 1.35% | 30 |
|
|
2017
Q2 | $15.9M | Sell |
284,940
-1,995
| -0.7% | -$109K | 1.2% | 32 |
|
|
2017
Q1 | $15.6M | Buy |
286,935
+70,715
| +33% | +$3.88M | 1.24% | 31 |
|
|
2016
Q4 | $12.6M | Sell |
216,220
-75,885
| -26% | -$4.15M | 1.04% | 39 |
|
|
2016
Q3 | $15.8M | Buy |
292,105
+146,350
| +100% | +$9.4M | 1.32% | 30 |
|
|
2016
Q2 | $10.7M | Buy |
145,755
+85,980
| +144% | +$6.08M | 0.93% | 41 |
|
|
2016
Q1 | $3.82M | Buy |
59,775
+54,000
| +935% | +$3.41M | 0.33% | 62 |
|
|
2015
Q4 | $397K | Hold |
5,775
| – | – | 0.03% | 114 |
|
|
2015
Q3 | $342K | Buy |
5,775
+1,000
| +21% | +$63.4K | 0.03% | 119 |
|
|
2015
Q2 | $318K | Buy |
4,775
+75
| +2% | +$4.94K | 0.03% | 130 |
|
|
2015
Q1 | $303K | Buy |
4,700
+2,100
| +81% | +$131K | 0.03% | 126 |
|
|
2014
Q4 | $153K | Sell |
2,600
-7,514
| -74% | -$424K | 0.01% | 176 |
|
|
2014
Q3 | $518K | Buy |
10,114
+350
| +4% | +$17.5K | 0.04% | 124 |
|
|
2014
Q2 | $474K | Sell |
9,764
-34,025
| -78% | -$1.68M | 0.04% | 125 |
|
|
2014
Q1 | $2.27M | Sell |
43,789
-44,015
| -50% | -$2.34M | 0.2% | 77 |
|
|
2013
Q4 | $4.67M | Sell |
87,804
-24,225
| -22% | -$1.23M | 0.41% | 60 |
|
|
2013
Q3 | $5.18M | Buy |
112,029
+690
| +0.6% | +$30.3K | 0.5% | 57 |
|
|
2013
Q2 | $4.98M | Buy |
+111,339
| New | +$4.83M | 0.5% | 54 |
|
Other funds holding BMY
Barrett Asset Management's BMY Position: Q1 2022 in Review
Barrett Asset Management sold out of Bristol-Myers Squibb (BMY) in Q1 2022, closing a stake of 5,347 shares — an estimated $333K sold.
Barrett Asset Management first reported a position in BMY in Q2 2013 and held it in 35 quarters. The position peaked at $18.9M in Q1 2018. 2,515 funds tracked by Wall St. Rank hold BMY as of Q1 2022.
- Barrett Asset Management reported no remaining Bristol-Myers Squibb position as of Q1 2022 after selling out during the quarter.
- Barrett Asset Management sold 5,347 Bristol-Myers Squibb shares in Q1 2022, an estimated $333K.
- Barrett Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 35 quarters.
- Barrett Asset Management's Bristol-Myers Squibb position peaked at $18.9M in Q1 2018.
- 2,515 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.
Based on Barrett Asset Management's 13F filing for Q1 2022, filed 16 May 2022.